Targeting Human Tumor Cells in Animals
Author Information
Author(s): J.G. Fjeld, O.S. Bruland, H.B. Benestad, L. Schjerven, T. Stigbrands, K. Nustad
Primary Institution: The Norwegian Radium Hospital
Hypothesis
Can a diffusion chamber model effectively target human tumor cells in immunocompetent animals?
Conclusion
The diffusion chamber model allows for effective targeting of human tumor cells in both mice and pigs.
Supporting Evidence
- The diffusion chamber model allows for the implantation of various target cells.
- Specific targeting of human tumor cells was demonstrated in both mice and pigs.
- The uptake of antibodies was lower in pigs than in mice, but the difference was smaller than expected.
Takeaway
Scientists created a special chamber to help target cancer cells in animals, which could help improve cancer treatments.
Methodology
The study used diffusion chambers implanted in the peritoneal cavity of mice and pigs to evaluate the targeting of human tumor cells with monoclonal antibodies.
Limitations
The model's predictive value may be limited due to differences in antibody clearance rates between species.
Participant Demographics
Mice were NMRI/Bom females aged 8-12 weeks, and pigs were female domestic pigs aged 4 months.
Want to read the original?
Access the complete publication on the publisher's website